Long term toxicity and prognostic factors of radiation therapy for secreting and non-secreting pituitary adenomas

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Rieken, Stefan ^a,b   Habermehl, Daniel ^a,b   Welzel, Thomas ^a,b   Mohr, Angela ^a,b   Lindel, Katja ^a   Debus, Jürgen ^a   Combs, Stephanie E ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adenoma; Endocrine; Pituitary; Secreting; Stereotactic; Toxicity

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHILD; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; SCHOOL CHILD; STEREOTACTIC TREATMENT; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL FIELD DEFECT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PITUITARY HORMONES; PITUITARY NEOPLASMS; PROGNOSIS; RADIATION TOLERANCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84872506255     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-18     Document Type: Article

References (23)

1. Isobe K, Ohta M, Yasuda S, Uno T, Hara R, Machida N, Saeki N, Yamaura A, Shigematsu N, Ito H. Postoperative radiation therapy for pituitary adenoma. J Neurooncol 2000, 48(2):135-140. 10.1023/A:1006477905230, 11083077.
2. Milker-Zabel S, Debus J, Thilmann C, Schlegel W, Wannenmacher M. Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys 2001, 50(5):1279-1286. 10.1016/S0360-3016(01)01535-8, 11483339.
3. Sun DQ, Cheng JJ, Frazier JL, Batra S, Wand G, Kleinberg LR, Rigamonti D, Quinones-Hinojosa A, Salvatori R, Lim M. Treatment of pituitary adenomas using radiosurgery and radiotherapy: a single center experience and review of literature. Neurosurg Rev 2010, 34(2):181-189.
4. Oruckaptan HH, Senmevsim O, Ozcan OE, Ozgen T. Pituitary adenomas: results of 684 surgically treated patients and review of the literature. Surg Neurol 2000, 53(3):211-219. 10.1016/S0090-3019(00)00171-3, 10773251.
5. Becker G, Kocher M, Kortmann RD, Paulsen F, Jeremic B, Muller RP, Bamberg M. Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol 2002, 178(4):173-186. 10.1007/s00066-002-0826-x, 12040754.
6. Weber DC, Momjian S, Pralong FP, Meyer P, Villemure JG, Pica A. Adjuvant or radical fractionated stereotactic radiotherapy for patients with pituitary functional and nonfunctional macroadenoma. Radiat Oncol 2011, 6:169. 10.1186/1748-717X-6-169, 3248375, 22152397.
7. Appelman-Dijkstra NM, Kokshoorn NE, Dekkers OM, Neelis KJ, Biermasz NR, Romijn JA, Smit JW, Pereira AM. Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96(8):2330-2340. 10.1210/jc.2011-0306, 3146793, 21613351.
8. Feigl GC, Pistracher K, Berghold A, Mokry M. Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas: the role of the hypothalamus. J Neurosurg 2010, 113(Suppl):153-159.
9. Darzy KH, Shalet SM. Hypopituitarism following Radiotherapy Revisited. Endocr Dev 2009, 15:1-24.
10. Lam KS, Tse VK, Wang C, Yeung RT, Ho JH. Effects of cranial irradiation on hypothalamic-pituitary function-a 5-year longitudinal study in patients with nasopharyngeal carcinoma. Q J Med 1991, 78(286):165-176.
11. Samaan NA, Schultz PN, Yang KP, Vassilopoulou-Sellin R, Maor MH, Cangir A, Goepfert H. Endocrine complications after radiotherapy for tumors of the head and neck. J Lab Clin Med 1987, 109(3):364-372.
12. Cifarelli CP, Schlesinger DJ, Sheehan JP. Cranial nerve dysfunction following Gamma Knife surgery for pituitary adenomas: long-term incidence and risk factors. J Neurosurg 2012, 116(6):1304-1310. 10.3171/2012.2.JNS111630, 22424563.
13. Hoshi M, Hayashi T, Kagami H, Murase I, Nakatsukasa M. Late bilateral temporal lobe necrosis after conventional radiotherapy. Neurol Med Chir (Tokyo) 2003, 43(4):213-216.
14. Bhansali A, Banerjee AK, Chanda A, Singh P, Sharma SC, Mathuriya SN, Dash RJ. Radiation-induced brain disorders in patients with pituitary tumours. Australas Radiol 2004, 48(3):339-346. 10.1111/j.0004-8461.2003.01237.x, 15344984.
15. Gopalan R, Schlesinger D, Vance ML, Laws E, Sheehan J. Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma. Neurosurgery 2011, 69(2):284-293. 10.1227/NEU.0b013e31821bc44e, 21792138.
16. Kobayashi T. Long-term results of stereotactic gamma knife radiosurgery for pituitary adenomas, Specific strategies for different types of adenoma. Prog Neurol Surg 2009, 22:77-95.
17. Winder MJ, Mayberg MR. Recent advances in pituitary tumor management. Curr Opin Endocrinol Diabetes Obes 2011, 18(4):278-288. 10.1097/MED.0b013e32834871f6, 21844711.
18. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clin Endocrinol (Oxf) 2006, 64(5):542-548.
19. Schalin-Jantti C, Valanne L, Tenhunen M, Setala K, Paetau A, Sane T, Kouri M. Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: a 5.25-year follow-up study. Clin Endocrinol (Oxf) 2010, 73(1):72-77.
20. Milker-Zabel S, Zabel A, Huber P, Schlegel W, Wannenmacher M, Debus J. Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma. Int J Radiat Oncol Biol Phys 2004, 59(4):1088-1096. 10.1016/j.ijrobp.2003.12.012, 15234043.
21. Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M. External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 1995, 33(2):307-314. 10.1016/0360-3016(95)00071-6, 7673017.
22. van Beek AP, van den Bergh AC, van den Berg LM, van den Berg G, Keers JC, Langendijk JA, Wolffenbuttel BH. Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for nonfunctioning pituitary adenoma. Int J Radiat Oncol Biol Phys 2007, 68(4):986-991. 10.1016/j.ijrobp.2007.01.017, 17379436.
23. Langsenlehner T, Stiegler C, Quehenberger F, Feigl GC, Jakse G, Mokry M, Langsenlehner U, Kapp KS, Mayer R. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome. Strahlenther Onkol 2007, 183(5):241-247. 10.1007/s00066-007-1706-1, 17497095.